1ouy: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
The quinazolinone and pyridol-pyrimidine classes of p38 MAP kinase, inhibitors have a previously unseen degree of specificity for p38 over, other MAP kinases. Comparison of the crystal structures of p38 bound to, four different compounds shows that binding of the more specific molecules, is characterized by a peptide flip between Met109 and Gly110. Gly110 is a, residue specific to the alpha, beta and gamma isoforms of p38. The delta, isoform and the other MAP kinases have bulkier residues in this position., These residues would likely make the peptide flip energetically, unfavorable, thus explaining the selectivity of binding. To test this, hypothesis, we constructed G110A and G110D mutants of p38 and measured the, potency of several compounds against them. The results confirm that the, selectivity of quinazolinones and pyridol-pyrimidines results from the, presence of a glycine in position 110. This unique mode of binding may be, exploited in the design of new p38 inhibitors.
The quinazolinone and pyridol-pyrimidine classes of p38 MAP kinase inhibitors have a previously unseen degree of specificity for p38 over other MAP kinases. Comparison of the crystal structures of p38 bound to four different compounds shows that binding of the more specific molecules is characterized by a peptide flip between Met109 and Gly110. Gly110 is a residue specific to the alpha, beta and gamma isoforms of p38. The delta isoform and the other MAP kinases have bulkier residues in this position. These residues would likely make the peptide flip energetically unfavorable, thus explaining the selectivity of binding. To test this hypothesis, we constructed G110A and G110D mutants of p38 and measured the potency of several compounds against them. The results confirm that the selectivity of quinazolinones and pyridol-pyrimidines results from the presence of a glycine in position 110. This unique mode of binding may be exploited in the design of new p38 inhibitors.


==About this Structure==
==About this Structure==
Line 14: Line 14:
[[Category: Non-specific serine/threonine protein kinase]]
[[Category: Non-specific serine/threonine protein kinase]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Becker, J.W.]]
[[Category: Becker, J W.]]
[[Category: Cameron, P.M.]]
[[Category: Cameron, P M.]]
[[Category: Fitzgerald, C.E.]]
[[Category: Fitzgerald, C E.]]
[[Category: Keefe, S.J.O.]]
[[Category: Keefe, S J.O.]]
[[Category: Patel, S.B.]]
[[Category: Patel, S B.]]
[[Category: Pikounis, V.B.]]
[[Category: Pikounis, V B.]]
[[Category: Scapin, G.]]
[[Category: Scapin, G.]]
[[Category: Zaller, D.]]
[[Category: Zaller, D.]]
Line 28: Line 28:
[[Category: map kinase]]
[[Category: map kinase]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 16:36:18 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:21:53 2008''